A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...

Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

The "Make America Healthy Again" commission is reviewing certain vaccines as some states push to restrict the use of COVID-19 ...

Moderna Inc. recorded a quarterly loss as vaccine sales waned and the company had an unexpected charge for a canceled ...

Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...

The American Pharmacists Association (APhA) has selected seven recipients of its 2025 Immunization Champion Awards, recognizing individuals and organizations who have made extraordinary contributions ...

Yale Researchers Find Possible Side Effects of Covid Vaccines ...

U.S. approves conditional use of avian influenza vaccine amid spreading outbreak U.S. greenlights temporary use of bird flu ...